Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.

about

A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patients.

P2860

Q47110205-AE164942-4AAA-4EB8-9BB5-4E5F8B96A656

P2860

Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.

Item

http://www.wikidata.org/entity/Q45063614

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.

@en

Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.

@nl

type

Item

label

Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.

@en

Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.

@nl

prefLabel

Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.

@en

Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.

@nl

P1476

Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.

@en

P2093

Daniel D Von Hoff

http://www.w3.org/2001/XMLSchema#string

Elizabeth Lenkiewicz

http://www.w3.org/2001/XMLSchema#string

Gayle Jameson

http://www.w3.org/2001/XMLSchema#string

Haiyong Han

http://www.w3.org/2001/XMLSchema#string

Jeffrey Drebin

http://www.w3.org/2001/XMLSchema#string

Lisa Evers

http://www.w3.org/2001/XMLSchema#string

Mark Sausen

http://www.w3.org/2001/XMLSchema#string

Michael T Barrett

http://www.w3.org/2001/XMLSchema#string

Peter O'Dwyer

http://www.w3.org/2001/XMLSchema#string

Ramesh K Ramanathan

http://www.w3.org/2001/XMLSchema#string

P2860

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

Targeting CDK4 and CDK6: From Discovery to Therapy

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma

A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

P2888

bjc.2017.209

P304

572-582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2017.209

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey Drebin

Victor Velculescu

P577

2017-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090742975

http://www.w3.org/2001/XMLSchema#string

P698

28720843

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

P932

5558689

http://www.w3.org/2001/XMLSchema#string

Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.

about

P2860

P2860

Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932